血糖監測設備市場規模、佔有率、成長分析、按產品、按應用、按地區 - 產業預測，2024-2031

Blood Glucose Monitoring Devices Market Size, Share, Growth Analysis, By Product (Blood Glucose Monitors, Glucose Monitoring Strips), By Application (Hospitals and Clinics, Diagnostic Centers), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月06日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球血糖監測設備市場規模為125億美元，從2023年的135.4億美元成長到2031年的237.7億美元，在預測期間（2024-2031）預計複合年成長率為8.30 %。

由於對有效糖尿病管理的需求不斷增加，血糖監測（BGM）市場正在顯著成長。 BGM 設備讓糖尿病患者可以使用血糖儀監測血糖值，使他們能夠就飲食、胰島素劑量和運動水平做出明智的決定。利用自我監測血糖（SMBG）技術，患者可以即時獲得毛細血管葡萄糖濃度的準確測量結果，有助於快速診斷低血糖和高血糖等病症。這項技術進步不僅增強了病人的自主權和自我護理，也鼓勵人們選擇更健康的生活方式。隨著血糖儀有各種形狀、尺寸和價格分佈，人們越來越認知到糖尿病管理解決方案的重要性。消費者意識的不斷增強預計將帶來巨大的市場機會，特別是在難以獲得糖尿病監測設備的開拓地區。在對更好的血糖控制和創新管理解決方案的持續需求的推動下，美國的自測血糖儀市場預計將持續成長。隨著糖尿病盛行率持續上升，在先進技術的整合和對糖尿病治療患者需求的深入了解的支持下，BGM 市場處於戰略擴張的地位。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Abbott（US）
Medtronic plc（Ireland）
F. Hoffmann-La Roche Ltd（Switzerland）
Dexcom, Inc.（US）
Sanofi（France）
Novo Nordisk（Denmark）
Insulet Corporation（US）
Ypsomed Holdings（Switzerland）
Glysens Incorporated
ARKRAY, Inc.（Japan）
Bayer AG（Germany）
AgaMatrix, Inc.（US）
Trividia Health, Inc.（US）
MediWise Ltd.（UK）
DiaMonTech AG（Germany）
B. Braun Melsungen AG（Germany）
Sinocare, Inc.（China）
Nipro Corporation（Japan）
Menarini Diagnostics（Italy）
Beurer GmbH（Germany）
Prodigy Diabetes Care, LLC（US）
Omron Healthcare, Inc.（Japan）

簡介目錄

Product Code: SQMIG35A2338

Global Blood Glucose Monitoring Devices Market size was valued at USD 12.50 billion in 2022 and is poised to grow from USD 13.54 billion in 2023 to USD 23.77 billion by 2031, growing at a CAGR of 8.30% during the forecast period (2024-2031).

The blood glucose monitoring (BGM) market is experiencing notable growth driven by the increasing demand for effective diabetes management. BGM devices enable individuals with diabetes to monitor their blood glucose levels using a glucose meter, allowing them to make informed decisions about their diet, insulin dosage, and physical activity. By utilizing self-monitoring blood glucose (SMBG) technology, patients can instantly obtain accurate readings of their capillary glucose concentration, facilitating rapid diagnosis of conditions such as hypoglycemia and hyperglycemia. This technological advancement not only enhances patient empowerment and self-care but also encourages healthier lifestyle choices. With a diverse range of glucose meters available in various shapes, sizes, and price points, there is a growing awareness of the importance of diabetes management solutions. This increasing consumer awareness is expected to fuel significant market opportunities, especially in underserved areas where diabetes monitoring devices are least accessible. The market for self-monitoring blood glucose devices in the U.S. is projected to achieve sustainable growth, driven by the ongoing demand for better glycemic control and innovative management solutions. As the prevalence of diabetes continues to rise, the BGM market strategically positions itself for expansion, supported by the integration of advanced technology and a deeper understanding of patient needs in diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Glucose Monitoring Devices Market Segmental Analysis

Global Blood Glucose Monitoring Devices Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Blood Glucose Monitors, Glucose Monitoring Strips, and Lancets. Based on Application, the market is segmented into Hospitals and Clinics, Diagnostic Centers, and Home Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Blood Glucose Monitoring Devices Market

The global Blood Glucose Monitoring Devices market is significantly driven by the alarming rise in diabetes prevalence, particularly among the aging population susceptible to the disease. With an estimated 537 million adults diagnosed globally, as reported by the International Diabetes Federation, countries like China, India, the United States, Brazil, and Mexico represent a staggering 51.6% of this demographic. Contributing factors such as rapid urbanization and increasingly sedentary lifestyles further exacerbate this public health concern. Additionally, heightened awareness about diabetes management and preventive care, along with continuous innovations in monitoring technology, is propelling market growth and driving the adoption of these essential devices.

Restraints in the Global Blood Glucose Monitoring Devices Market

The global blood glucose monitoring devices market faces significant restraints from the high costs associated with these devices and the inadequacy of reimbursements. In developing nations like China and India, the burden of purchasing blood glucose monitors and test strips falls solely on patients, leading to limited accessibility and affordability. In contrast, developed countries such as Canada and certain European nations impose restrictions on the number of annually provided test strips based on specific treatment plans, discouraging comprehensive monitoring for many patients. This situation ultimately curtails market growth, as patients often forego necessary monitoring due to financial constraints.

Market Trends of the Global Blood Glucose Monitoring Devices Market

The Global Blood Glucose Monitoring Devices market is experiencing significant growth driven by technological advancements and innovative solutions aimed at improving patient care. As medical device companies shift from traditional manufacturing to becoming problem solvers, the integration of cloud computing and the Internet of Things (IoT) is revolutionizing diabetes management. Cutting-edge devices, including non-invasive monitoring solutions utilizing radio frequency and multi-sensor technology, as well as optical methods for glucose measurement, enhance accuracy and user-friendliness. This trend towards more sophisticated and connected devices not only caters to the rising prevalence of diabetes but also supports real-time remote monitoring, thereby enhancing clinical outcomes and reducing healthcare costs.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Blood Glucose Monitoring Devices Market by Product

Market Overview
Blood Glucose Monitors
- Single Point Blood Glucose Meters
- Continuous Glucose Monitoring Systems
- Sensors
- Transmitter and Receivers
- External Monitor
Glucose Monitoring Strips
Lancets

Blood Glucose Monitoring Devices Market by Application

Market Overview
Hospitals and Clinics
Diagnostic Centers
Home Settings

Blood Glucose Monitoring Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holdings (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glysens Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARKRAY, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trividia Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MediWise Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaMonTech AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinocare, Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menarini Diagnostics (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beurer GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prodigy Diabetes Care, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omron Healthcare, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments